FDA inspection
Daniel A. Nadeau, MD, Diabetes Endocrine & Nutrition Center: FDA inspection ending Apr 19, 2000
FDA inspection 21743 · No Action Indicated (NAI) · Bangor, ME
Key facts
| Inspection ID | 21743 |
|---|---|
| Firm | Daniel A. Nadeau, MD, Diabetes Endocrine & Nutrition Center |
| FEI number | 3001451550 |
| Address | 905 Union St Ste 11 |
| City | Bangor |
| State | ME |
| ZIP | 04401-3039 |
| Fiscal year | 2000 |
| Inspection end date | Apr 19, 2000 |
| Classification | No Action Indicated (NAI) |
| Project area | Human Cellular, Tissue and Gene Therapies |
| Product type | Biologics, Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data